The Role of Denosumab for Surgical Outcomes in Patients with Giant Cell Tumour of Bone: A Systematic Review

Background: The role of denosumab in patients with resectable giant cell tumour of bone remains unclear. We asked the following research question: for patients (aged ≥ 12 years) with resectable giant cell tumour of bone, what are the benefits and harms of denosumab compared with no denosumab in term...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Abha, Durocher-Allen, Lisa, Popovic, Snezana, Tozer, Richard, Yao, Xiaomei, Ghert, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025825/
https://www.ncbi.nlm.nih.gov/pubmed/33809979
http://dx.doi.org/10.3390/curroncol28020124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025825/
https://www.ncbi.nlm.nih.gov/pubmed/33809979
http://dx.doi.org/10.3390/curroncol28020124

Ejemplares similares